Risk of thrombotic events in immune thrombocytopenia patients treated with thrombopoietic agents: a systematic review and meta-analysis

Risk of thrombotic events in immune thrombocytopenia patients treated with thrombopoietic agents: a systematic review and meta-analysis

Abstract Background Immune thrombocytopenia (ITP), which is a well-known hemorrhagic disorder characterized by low platelet counts, has been shown to be associated with the risk of thrombosis. Thrombopoietic agents (TAs) are extensively used as second-line treatments for ITP, effectively reducing th...

Full description

Bibliographic Details
Main Authors: Yu Dong, Zhinan Xia, Jie Zhou, Yutao Hu, Ming Yue, Yuyong Wang, Mengjiao Hu
Format: Article
Language:English
Published: BMC 2023-06-01
Series:Thrombosis Journal
Subjects:
Immune thrombocytopenia
Platelet
Thrombopoietic agents
Thrombotic event
Meta-analysis
Online Access:https://doi.org/10.1186/s12959-023-00509-z

Similar Items

Similar Items